CF PHARMTECH (02652)

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

CF PHARMTECH (02652)

CF PharmTech, Inc. engages in research and development, production, and sale of respiratory drugs in the field of respiratory diseases in China. It offers Shufeimin, an azelastine hydrochloride and fluticasone propionate nasal spray; ChangQi, a budesonide inhalation suspension solution; ChangShu, a salbutamol sulfate inhalation solution; and piezoelectric mesh nebulizer, electric nasal cleaner, BFS hypertonic and physiologi

CS Hotline: +852 3018 4526

Trading days: 24 hours | Non-trading days: 9:00-18:00

Headquarters

Sheung Wan

Address: Room 2405-06, 24/F, 308 Central Des Voeux, Sheung Wan, Hong Kong

North District

Address: 1718-1721, Level 17 Landmark North, 39 Lung Sum Avenue, Sheung Shui, New Territories, Hong Kong

Email: cs@usmart.hk

WhatsApp: +852 5989 2641

uSMART Branches(Causeway Bay coming soon)

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907) holding Type 1 Licence for Dealing in Securities, Type 4 Licence for Advising on Securities, Type 6 Licence for Advising on Corporate Finance, and Type 9 Licence for Asset Management.

Market News

CF PHARMTECH (02652)

Services

About Us

Agreement Statement